drugset / Trial / NCT04300452
Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage
RandomizedParallel-groupDouble-blindPrevention
Summary
In the present study will be compared Carbetocin with ergometrin in the prevention of postpartum haemorrhage (PPH) in parturients that are undergoing caesarean section and are not presenting risk factors for PPH. As indicators will be used intraoperative blood loss, as well as the value of hemoglobin and hematocrit 24 hours after the caesarian section.
Timeline
- Start
- 2018-04-05
- Primary completion
- 2020-06-10
- Completion
- 2020-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carbetocin | Peptide | 100 ug | Intravenous |
| Comparator | ergometrine | Unknown | 0.2 mg | Intravenous |
Indications
No indication recorded.